Home » Esme Norbury

Esme Norbury

Senior Analyst

Esme Norbury is a Senior Analyst at CBPartners.

Connect with Esme Norbury



Published Articles

Assessing the Value of Non-Curative Cell and Gene Therapies

Some cell and gene therapies without a curative promise have shown encouraging results for patients with chronic disorders, however manufacturers need to carefully design a value strategy for their non-curative assets to ensure maximum access and uptake in their target markets.